English
Zoom-Zoom+Black contrastBlue contrastWhite contrast

How to use the speech recognition tool?

NCT02410122

PROGSTAR-4 STUDY

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy (ProgStar-4).

Type: Observational



Status of the trial: Completed

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2014-12-12
  • Closing Date: 2018-03-31

Criteria

Inclusion: Participants with PROM1 mutations and associated STGD4 phenotype

More information

Children: No

Adults: No

Funder Type: patient organisation

Principal location of the trial

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: